Michiya Nishino, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Nodule | 13 | 2023 | 765 | 4.690 |
Why?
|
Thyroid Neoplasms | 18 | 2024 | 2355 | 3.870 |
Why?
|
Adenocarcinoma, Follicular | 8 | 2023 | 323 | 2.290 |
Why?
|
Biopsy, Fine-Needle | 14 | 2024 | 1131 | 2.060 |
Why?
|
Cytodiagnosis | 8 | 2024 | 450 | 1.650 |
Why?
|
Molecular Diagnostic Techniques | 6 | 2023 | 614 | 1.440 |
Why?
|
Carcinoma, Neuroendocrine | 3 | 2024 | 343 | 1.370 |
Why?
|
Thyroid Gland | 4 | 2020 | 1170 | 1.320 |
Why?
|
Carcinoma, Papillary | 4 | 2021 | 791 | 0.980 |
Why?
|
Salivary Gland Neoplasms | 3 | 2021 | 306 | 0.820 |
Why?
|
Adenolymphoma | 1 | 2020 | 11 | 0.730 |
Why?
|
Adenoma, Pleomorphic | 1 | 2020 | 77 | 0.680 |
Why?
|
Laboratories | 1 | 2021 | 463 | 0.590 |
Why?
|
Head and Neck Neoplasms | 3 | 2024 | 2930 | 0.570 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2022 | 492 | 0.530 |
Why?
|
Immunodominant Epitopes | 1 | 2016 | 244 | 0.480 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2016 | 308 | 0.460 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 2013 | 28 | 0.440 |
Why?
|
Esthesioneuroblastoma, Olfactory | 2 | 2024 | 58 | 0.410 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2021 | 8623 | 0.380 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3610 | 0.380 |
Why?
|
Pulmonary Aspergillosis | 1 | 2012 | 48 | 0.370 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2011 | 41 | 0.370 |
Why?
|
Bronchoalveolar Lavage | 1 | 2011 | 131 | 0.370 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2024 | 243 | 0.360 |
Why?
|
Fibrin | 1 | 2013 | 514 | 0.360 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1639 | 0.340 |
Why?
|
Pleural Neoplasms | 1 | 2014 | 584 | 0.330 |
Why?
|
Hemangiosarcoma | 1 | 2012 | 214 | 0.330 |
Why?
|
Thoracic Neoplasms | 1 | 2012 | 269 | 0.330 |
Why?
|
Lung | 3 | 2013 | 10068 | 0.330 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2011 | 757 | 0.320 |
Why?
|
Mesothelioma | 1 | 2014 | 774 | 0.310 |
Why?
|
Breast Implants | 1 | 2012 | 414 | 0.290 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2020 | 3667 | 0.290 |
Why?
|
Hair Diseases | 1 | 2008 | 72 | 0.280 |
Why?
|
Epidermal Cyst | 1 | 2008 | 63 | 0.280 |
Why?
|
Adenocarcinoma, Papillary | 2 | 2021 | 86 | 0.280 |
Why?
|
Foreign-Body Reaction | 1 | 2008 | 156 | 0.280 |
Why?
|
Gene Rearrangement | 1 | 2012 | 1141 | 0.280 |
Why?
|
Metaphase | 1 | 2006 | 143 | 0.270 |
Why?
|
Quality Improvement | 1 | 2021 | 3850 | 0.260 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3235 | 0.260 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2801 | 0.250 |
Why?
|
Kinetochores | 1 | 2006 | 172 | 0.240 |
Why?
|
Humans | 48 | 2025 | 766812 | 0.240 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2012 | 1621 | 0.240 |
Why?
|
Gene Expression Profiling | 3 | 2019 | 9528 | 0.220 |
Why?
|
Diagnosis, Differential | 7 | 2025 | 12985 | 0.220 |
Why?
|
Peptide Fragments | 2 | 2016 | 5143 | 0.220 |
Why?
|
von Hippel-Lindau Disease | 1 | 2025 | 154 | 0.220 |
Why?
|
Nose Neoplasms | 2 | 2024 | 250 | 0.220 |
Why?
|
Tongue Neoplasms | 1 | 2025 | 185 | 0.210 |
Why?
|
Breast | 1 | 2012 | 1972 | 0.210 |
Why?
|
Salivary Glands | 2 | 2021 | 231 | 0.200 |
Why?
|
Carcinoma | 3 | 2022 | 2325 | 0.200 |
Why?
|
Biopsy | 5 | 2024 | 6779 | 0.200 |
Why?
|
Cell Cycle Proteins | 4 | 2016 | 3440 | 0.190 |
Why?
|
Transcription Factors | 2 | 2024 | 12159 | 0.190 |
Why?
|
Retrospective Studies | 12 | 2023 | 81657 | 0.180 |
Why?
|
Lung Neoplasms | 4 | 2024 | 13489 | 0.180 |
Why?
|
Specimen Handling | 1 | 2024 | 706 | 0.170 |
Why?
|
Nuclear Proteins | 4 | 2024 | 5795 | 0.170 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2022 | 705 | 0.160 |
Why?
|
Adenocarcinoma | 2 | 2016 | 6359 | 0.160 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2018 | 24 | 0.150 |
Why?
|
Technology | 1 | 2020 | 296 | 0.150 |
Why?
|
Coccidioidomycosis | 1 | 2017 | 36 | 0.140 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5389 | 0.140 |
Why?
|
Risk Assessment | 3 | 2024 | 24299 | 0.140 |
Why?
|
Lung Diseases, Fungal | 1 | 2017 | 123 | 0.140 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2018 | 238 | 0.130 |
Why?
|
Papillomaviridae | 1 | 2022 | 1139 | 0.130 |
Why?
|
DNA, Viral | 1 | 2022 | 2201 | 0.120 |
Why?
|
Family Characteristics | 1 | 2020 | 1002 | 0.120 |
Why?
|
Oxyphil Cells | 1 | 2015 | 56 | 0.120 |
Why?
|
Cytokinesis | 1 | 2016 | 170 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 2 | 2006 | 4523 | 0.120 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15425 | 0.110 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 545 | 0.110 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 934 | 0.110 |
Why?
|
Protein Array Analysis | 1 | 2015 | 399 | 0.110 |
Why?
|
Dyspnea | 2 | 2012 | 1352 | 0.110 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 415 | 0.110 |
Why?
|
Immunoenzyme Techniques | 1 | 2016 | 1697 | 0.100 |
Why?
|
Poland Syndrome | 1 | 2012 | 14 | 0.100 |
Why?
|
Mitosis | 2 | 2016 | 1176 | 0.100 |
Why?
|
Silicone Gels | 1 | 2012 | 39 | 0.100 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2012 | 80 | 0.100 |
Why?
|
Radiography | 2 | 2013 | 6968 | 0.090 |
Why?
|
raf Kinases | 1 | 2012 | 117 | 0.090 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9613 | 0.090 |
Why?
|
Adult | 11 | 2024 | 223305 | 0.080 |
Why?
|
Middle Aged | 13 | 2025 | 223267 | 0.080 |
Why?
|
Macrophages, Alveolar | 1 | 2011 | 413 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59548 | 0.080 |
Why?
|
Immunohistochemistry | 5 | 2024 | 11062 | 0.080 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2012 | 238 | 0.070 |
Why?
|
Male | 16 | 2025 | 364154 | 0.070 |
Why?
|
Genetic Testing | 1 | 2021 | 3591 | 0.070 |
Why?
|
Aged | 10 | 2024 | 171344 | 0.070 |
Why?
|
Cough | 1 | 2011 | 599 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2020 | 2056 | 0.070 |
Why?
|
Fatal Outcome | 1 | 2012 | 1838 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4114 | 0.070 |
Why?
|
MAP Kinase Signaling System | 2 | 2012 | 1492 | 0.070 |
Why?
|
Chromosome Positioning | 1 | 2006 | 18 | 0.070 |
Why?
|
Female | 13 | 2024 | 396532 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 2456 | 0.070 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2012 | 2510 | 0.060 |
Why?
|
Dyneins | 2 | 2004 | 126 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2025 | 4050 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2882 | 0.060 |
Why?
|
Adenoma | 1 | 2016 | 2155 | 0.060 |
Why?
|
Mutation | 4 | 2024 | 30214 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4747 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1834 | 0.050 |
Why?
|
Paraffin Embedding | 1 | 2024 | 303 | 0.050 |
Why?
|
Tissue Fixation | 1 | 2024 | 245 | 0.050 |
Why?
|
Prolactin | 1 | 2005 | 628 | 0.050 |
Why?
|
Microtubules | 2 | 2006 | 1063 | 0.050 |
Why?
|
Phosphorylation | 3 | 2016 | 8310 | 0.050 |
Why?
|
Respiratory Insufficiency | 1 | 2012 | 1241 | 0.050 |
Why?
|
Formaldehyde | 1 | 2024 | 360 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 911 | 0.050 |
Why?
|
Sulfonamides | 1 | 2012 | 1982 | 0.050 |
Why?
|
Pyrazoles | 1 | 2012 | 2030 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2003 | 432 | 0.050 |
Why?
|
Herpes Simplex | 1 | 2025 | 470 | 0.050 |
Why?
|
Simplexvirus | 1 | 2025 | 805 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2021 | 65286 | 0.050 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2006 | 724 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8507 | 0.050 |
Why?
|
Protein Transport | 1 | 2006 | 1944 | 0.040 |
Why?
|
Pyridines | 1 | 2012 | 2888 | 0.040 |
Why?
|
Advisory Committees | 1 | 2024 | 797 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14653 | 0.040 |
Why?
|
Patient Selection | 1 | 2012 | 4252 | 0.040 |
Why?
|
Nasal Cavity | 1 | 2022 | 310 | 0.040 |
Why?
|
Proteins | 2 | 2005 | 6002 | 0.040 |
Why?
|
Young Adult | 4 | 2020 | 59939 | 0.040 |
Why?
|
Immunocompromised Host | 1 | 2025 | 865 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14073 | 0.040 |
Why?
|
Fungal Proteins | 1 | 2003 | 901 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2004 | 1073 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12064 | 0.040 |
Why?
|
Gene Fusion | 1 | 2021 | 356 | 0.040 |
Why?
|
Myofibroblasts | 1 | 2020 | 230 | 0.040 |
Why?
|
RNA Interference | 1 | 2006 | 2829 | 0.040 |
Why?
|
Logistic Models | 1 | 2012 | 13276 | 0.040 |
Why?
|
Hyphae | 1 | 2017 | 52 | 0.040 |
Why?
|
Spores, Fungal | 1 | 2017 | 89 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20146 | 0.040 |
Why?
|
Pancreas | 1 | 2024 | 1698 | 0.030 |
Why?
|
Pain | 1 | 2012 | 5098 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2005 | 2140 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2005 | 2448 | 0.030 |
Why?
|
Phenotype | 2 | 2012 | 16722 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5690 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2856 | 0.030 |
Why?
|
beta Catenin | 1 | 2020 | 1048 | 0.030 |
Why?
|
HeLa Cells | 2 | 2016 | 3073 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1334 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2003 | 2875 | 0.030 |
Why?
|
Adenoma, Oxyphilic | 1 | 2015 | 151 | 0.030 |
Why?
|
Models, Biological | 2 | 2006 | 9464 | 0.030 |
Why?
|
Endosomes | 1 | 2015 | 521 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 804 | 0.020 |
Why?
|
Mice, Nude | 2 | 2012 | 3618 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6965 | 0.020 |
Why?
|
HT29 Cells | 1 | 2012 | 187 | 0.020 |
Why?
|
Prognosis | 1 | 2012 | 29959 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 381 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 18076 | 0.020 |
Why?
|
Cell Line, Tumor | 3 | 2015 | 17089 | 0.020 |
Why?
|
Adenoviridae | 2 | 2004 | 1093 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13644 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1117 | 0.020 |
Why?
|
Apoptosis | 1 | 2005 | 9514 | 0.020 |
Why?
|
Adolescent | 2 | 2016 | 88902 | 0.020 |
Why?
|
Down-Regulation | 2 | 2005 | 2931 | 0.020 |
Why?
|
Risk Factors | 1 | 2014 | 74889 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5444 | 0.020 |
Why?
|
Cell Division | 2 | 2004 | 4473 | 0.020 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2005 | 69 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4892 | 0.010 |
Why?
|
STAT1 Transcription Factor | 1 | 2005 | 340 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2005 | 513 | 0.010 |
Why?
|
G2 Phase | 1 | 2004 | 134 | 0.010 |
Why?
|
bcl-X Protein | 1 | 2005 | 412 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2012 | 3605 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9346 | 0.010 |
Why?
|
Mice | 4 | 2015 | 81898 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 694 | 0.010 |
Why?
|
Cell Size | 1 | 2004 | 625 | 0.010 |
Why?
|
Protein Binding | 2 | 2005 | 9326 | 0.010 |
Why?
|
Animals | 6 | 2015 | 168939 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2005 | 1251 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 11094 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2005 | 2177 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13642 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2004 | 2012 | 0.010 |
Why?
|
Immunoblotting | 1 | 2003 | 1647 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2004 | 1206 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 1405 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3759 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2005 | 2093 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2004 | 3093 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21527 | 0.010 |
Why?
|
NF-kappa B | 1 | 2005 | 2493 | 0.010 |
Why?
|
Binding Sites | 1 | 2005 | 6013 | 0.010 |
Why?
|
Gene Silencing | 1 | 2003 | 1505 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4143 | 0.010 |
Why?
|
Protein Kinases | 1 | 2003 | 1610 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2004 | 2391 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5755 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 5502 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6507 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2003 | 3427 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2003 | 1474 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 13411 | 0.010 |
Why?
|
RNA | 1 | 2003 | 2715 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2005 | 3582 | 0.010 |
Why?
|
Cohort Studies | 1 | 2015 | 41706 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23618 | 0.010 |
Why?
|
Gene Expression | 1 | 2004 | 7585 | 0.010 |
Why?
|
Cell Movement | 1 | 2003 | 5204 | 0.010 |
Why?
|
DNA | 1 | 2004 | 7210 | 0.010 |
Why?
|
Rats | 1 | 2005 | 23717 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10263 | 0.000 |
Why?
|
Neurons | 1 | 2003 | 9515 | 0.000 |
Why?
|
Time Factors | 1 | 2003 | 40149 | 0.000 |
Why?
|